Video

WEBINAR | Monitoring of Glycosylation Using Site Specific Approaches for Antibody-based Therapeutics

Watch Video

WEBINAR | Monitoring of Glycosylation Using Site Specific Approaches for Antibody-based Therapeutics

Antibody-based Therapeutics N-linked glycosylation is a common post-translational modification on many antibody-based therapeutics, and has been linked to safety, stability and activity. Modification should therefore be monitored and controlled.


During this webcast, our expert Michael Walker discusses peptide mapping and middle-up mass spectrometry as characterization techniques that give relative levels of different glycoforms at specific sites, and compares to more common methodologies of enzymatic stripping and fluorescent labelling.

Other Content from Intertek Pharmaceutical Services